Correlation Between NanoVibronix and Talis Biomedical

Can any of the company-specific risk be diversified away by investing in both NanoVibronix and Talis Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NanoVibronix and Talis Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between NanoVibronix and Talis Biomedical Corp, you can compare the effects of market volatilities on NanoVibronix and Talis Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NanoVibronix with a short position of Talis Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of NanoVibronix and Talis Biomedical.

Diversification Opportunities for NanoVibronix and Talis Biomedical

-0.31

Correlation Coefficient

NanoVibronix  Talis Biomedical

Very good diversification

The 3 months correlation between NanoVibronix and Talis is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding NanoVibronix and Talis Biomedical Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Talis Biomedical Corp and NanoVibronix is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NanoVibronix are associated (or correlated) with Talis Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Talis Biomedical Corp has no effect on the direction of NanoVibronix i.e., NanoVibronix and Talis Biomedical go up and down completely randomly.

Pair Corralation between NanoVibronix and Talis Biomedical

Given the investment horizon of 90 days NanoVibronix is expected to generate 0.12 times more return on investment than Talis Biomedical. However, NanoVibronix is 8.22 times less risky than Talis Biomedical. It trades about 0.1 of its potential returns per unit of risk. Talis Biomedical Corp is currently generating about -0.75 per unit of risk. If you would invest  57.00  in NanoVibronix on August 30, 2024 and sell it today you would earn a total of  16.00  from holding NanoVibronix or generate 28.07% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	7.81%
Values	Daily Returns

NanoVibronix  vs.  Talis Biomedical Corp

NanoVibronix

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in NanoVibronix are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile basic indicators, NanoVibronix showed solid returns over the last few months and may actually be approaching a breakup point.

Talis Biomedical Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Talis Biomedical Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's forward indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with NanoVibronix and Talis Biomedical

The main advantage of trading using opposite NanoVibronix and Talis Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NanoVibronix position performs unexpectedly, Talis Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Talis Biomedical will offset losses from the drop in Talis Biomedical's long position.

The idea behind NanoVibronix and Talis Biomedical Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.